Document ID: chunk:federal_register_of_legislation:F2024C00880:reg:10
Version: federal_register_of_legislation:F2024C00880
Segment Type: reg
Provision Reference: reg 10
Character Range: 17848–19392

10  Definitions relating to doses of somatropin
 (1) For the purposes of table items 1 to 4 of the table in section 11:
dose, for a person and a pharmaceutical benefit, means a dose of pharmaceutical benefit mentioned in the table in section 11 that is measured as a dose that applies to the body surface area of the person for a week, with the body surface area of the person calculated using the formula:

 (2) For the purposes of table items 1 to 3 of the table in section 11, the measurement 'm2' refers to:
 (a) where a person is:
 (i) mentioned in item 1 or 2 in the table in section 11; or
 (ii) mentioned in item 3 in the table in section 11 and has a body mass index less than the 85th percentile for age and sex;
a square metre of the body surface area of the person calculated by weight; or
 (b) where a person is:
 (i) mentioned in item 3 in the table in section 11; and
 (ii) has a body mass index greater than the 85th percentile for age and sex,
a square metre of the body surface area of the person, calculated using ideal body weight (kg).
 (3) For the purposes of table item 4 of the table in section 11, the measurement 'kg' refers to:
 (a) where a person is mentioned in item 4 in the table in section 11 and has a body mass index equal to or less than the 85th percentile for age and sex, the person's body weight in kilograms; or
 (b) where a person is mentioned in item 4 in the table in section 11 and has a body mass index greater than the 85th percentile for age and sex, the person's ideal body weight in kilograms.